# Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation

Study · id `cardio:ct-nct02687932` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02687932](<https://clinicaltrials.gov/study/NCT02687932>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02687932

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.

## Technical summary

Registry record NCT02687932. Randomized; quadruple masking; primary purpose treatment. Start 2016-03 (actual); primary completion 2018-01-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 118 participants (enrolled count; ClinicalTrials.gov record NCT02687932, source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)
- Started: 2016-03 (actual) (ClinicalTrials.gov record NCT02687932, source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)
- Primary completion: 2018-01-02 (actual) (ClinicalTrials.gov record NCT02687932, source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)
- Completion: 2018-01-02 (actual) (ClinicalTrials.gov record NCT02687932, source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02687932, source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02687932-2018-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
- Acronym: PRIME
- Condition: Mitral Valve Insufficiency
- Condition: Left Ventricular Dysfunction
- Intervention (Drug): LCZ696
- Intervention (Drug): Valsartan
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Novartis
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry intervention name matches this record: Sacubitril/valsartan (combination) (`cardio:sacubitril-valsartan`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Novartis (`cardio:novartis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation (`cardio:pubmed-30586756`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a9788c90ea8b19224d791129ba6a8af48330afca55d996048be8ecb1ff3418e3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
